» Articles » PMID: 28535915

Virtual Patient 3D Dose Reconstruction Using in Air EPID Measurements and a Back-projection Algorithm for IMRT and VMAT Treatments

Overview
Journal Phys Med
Date 2017 May 25
PMID 28535915
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: At our institute, a transit back-projection algorithm is used clinically to reconstruct in vivo patient and in phantom 3D dose distributions using EPID measurements behind a patient or a polystyrene slab phantom, respectively. In this study, an extension to this algorithm is presented whereby in air EPID measurements are used in combination with CT data to reconstruct 'virtual' 3D dose distributions. By combining virtual and in vivo patient verification data for the same treatment, patient-related errors can be separated from machine, planning and model errors.

Methods And Materials: The virtual back-projection algorithm is described and verified against the transit algorithm with measurements made behind a slab phantom, against dose measurements made with an ionization chamber and with the OCTAVIUS 4D system, as well as against TPS patient data. Virtual and in vivo patient dose verification results are also compared.

Results: Virtual dose reconstructions agree within 1% with ionization chamber measurements. The average γ-pass rate values (3% global dose/3mm) in the 3D dose comparison with the OCTAVIUS 4D system and the TPS patient data are 98.5±1.9%(1SD) and 97.1±2.9%(1SD), respectively. For virtual patient dose reconstructions, the differences with the TPS in median dose to the PTV remain within 4%.

Conclusions: Virtual patient dose reconstruction makes pre-treatment verification based on deviations of DVH parameters feasible and eliminates the need for phantom positioning and re-planning. Virtual patient dose reconstructions have additional value in the inspection of in vivo deviations, particularly in situations where CBCT data is not available (or not conclusive).

Citing Articles

Long-term performance monitoring of a-Si 1200 electronic portal imaging device for dosimetric applications.

Kutuzov I, Rivest R, VanUytven E, McCurdy B J Appl Clin Med Phys. 2024; 26(1):e14551.

PMID: 39374243 PMC: 11713653. DOI: 10.1002/acm2.14551.


Research on the correction method for radiotherapy verification plans based on displaced electronic portal imaging device.

Guo J, Zhou L, Zeng H J Appl Clin Med Phys. 2024; 25(8):e14401.

PMID: 38778555 PMC: 11302800. DOI: 10.1002/acm2.14401.


AAPM Task Group Report 307: Use of EPIDs for Patient-Specific IMRT and VMAT QA.

Dogan N, Mijnheer B, Padgett K, Nalichowski A, Wu C, Nyflot M Med Phys. 2023; 50(8):e865-e903.

PMID: 37384416 PMC: 11230298. DOI: 10.1002/mp.16536.


Clinical rationale for portal dosimetry in magnetic resonance guided online adaptive radiotherapy.

Vivas Maiques B, Ruiz I, Janssen T, Mans A Phys Imaging Radiat Oncol. 2022; 23:16-23.

PMID: 35734264 PMC: 9207286. DOI: 10.1016/j.phro.2022.06.005.


Extending portal dosimetry with dose inhomogeneity conversion maps for accurate patient dose reconstruction in external beam radiotherapy.

Olaciregui-Ruiz I, Osinga-Blaettermann J, Ortega-Marin K, Mijnheer B, Mans A Phys Imaging Radiat Oncol. 2022; 22:20-27.

PMID: 35493851 PMC: 9038561. DOI: 10.1016/j.phro.2022.04.001.